PROCEPT BioRobotics Corp. (PRCT)
19.19
-1.11
(-5.47%)
USD |
NASDAQ |
Oct 30, 16:00
19.19
0.00 (0.00%)
After-Hours: 20:00
PROCEPT BioRobotics Cash from Operations (Quarterly) : -19.25M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -19.25M |
| March 31, 2026 | -38.13M |
| December 31, 2025 | -10.33M |
| September 30, 2025 | -6.635M |
| June 30, 2025 | -15.04M |
| March 31, 2025 | -16.98M |
| December 31, 2024 | -32.39M |
| September 30, 2024 | -18.80M |
| June 30, 2024 | -15.74M |
| March 31, 2024 | -32.29M |
| December 31, 2023 | -24.79M |
| September 30, 2023 | -18.94M |
| Date | Value |
|---|---|
| June 30, 2023 | -28.34M |
| March 31, 2023 | -35.93M |
| December 31, 2022 | -25.17M |
| September 30, 2022 | -19.85M |
| June 30, 2022 | -17.13M |
| March 31, 2022 | -18.23M |
| December 31, 2021 | -16.48M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -15.20M |
| December 31, 2020 | -13.44M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Insulet Corp. | 88.50M |
| Beta Bionics, Inc. | -12.29M |
| Abbott Laboratories | -- |
| Baxter International, Inc. | -- |
| Becton, Dickinson & Co. | 652.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -2.953M |
| Cash from Financing (Quarterly) | 4.496M |
| Free Cash Flow | -84.92M |
| Free Cash Flow Per Share (Quarterly) | -0.3891 |
| Free Cash Flow to Equity (Quarterly) | -21.71M |
| Free Cash Flow to Firm (Quarterly) | -21.36M |
| Free Cash Flow Yield | -7.85% |